X-BAT

The German-French X-BAT consortium focuses on the research on and generation of a decavalent equine antitoxin counteracting deliberate attacks with all currently known botulinum neurotoxin types. By means of innovative antigen design and state-of-the-art production new routes in the generation of sufficient volumes of life saving BoNT antitoxin are explored. The consortium aims at providing a highly available, EU-licensable treatment of civilians and civil security forces upon deliberate BoNT intoxications.

X-BAT is being funded by the Agence Nationale de la Recherche (ANR) and the German Federal Ministry of Education and Research (BMBF) within the framework of the Franco-German cooperation in security research.

Partners

Organised by

SRE environmental policy

Carbon neutral

In 2022, the Security Research Event is committed to compensate its carbon footprint by investing in certified carbon-offset projects supporting local communities worldwide.